FDA Inspection 733882 — Teva Pharmaceutical Industries
The FDA completed an inspection of Teva Pharmaceutical Industries on June 19, 2011 in Jerusalem. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 19, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jerusalem (Israel)